In humans, reduced levels of the BCL11B protein are a key event in the multistep progression of adult T cell leukemia and lymphoma (ATLL)61 and BCL11B was aberrantly expressed in a cohort of T-ALL patients whereby low expression predicted inferior survival.62 This evidence concerns the gene BCL11B and adult T-cell leukemia/lymphoma.